শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

tonus elast nicas novads, nicas pagasts lv-3473 pilskalni lotyšsko -

শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

tonus elast nicas novads, nicas pagasts lv-3473 pilskalni lotyšsko -

শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

tonus elast nicas novads, nicas pagasts lv-3473 pilskalni lotyšsko -

শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

tonus elast nicas novads, nicas pagasts lv-3473 pilskalni lotyšsko -

শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

imuna pharm, a.s., slovensko - elektrolyty - 76 - infundibilia

শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

bb pharma a.s. - elektrolyty - 87 - varia i

শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

imuna pharm, a.s., slovensko - elektrolyty so sacharidmi - 76 - infundibilia

ইউরোপীয় ইউনিয়ন - স্লোভাক - EMA (European Medicines Agency)

extrovis eu ltd. - lakosamid - epilepsie - antiepileptiká, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

ইউরোপীয় ইউনিয়ন - স্লোভাক - EMA (European Medicines Agency)

accord healthcare s.l.u. - lakosamid - epilepsie - antiepileptiká, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

ইউরোপীয় ইউনিয়ন - স্লোভাক - EMA (European Medicines Agency)

biocodex - stiripentol - myoklonickou epilepsiou, mladistvých - antiepileptiká, - diacomit je indikovaný na použitie spoločne s klobazamom a valproátom ako doplnková liečba refraktérnej generalizované tonicko-klonické záchvaty u pacientov s ťažkou detskou v detstve (smei, dravetov syndróm), ktorého záchvaty nie sú dostatočne kontrolované s klobazamom a valproátom.